Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carlos Singer

Showing results (121-130 of 133) with videos related to

Pageof 14
Sort By:
JAMA|February 11, 2015
Effect of creatine monohydrate on clinical progression in patients with Parkinson disease: a randomized clinical trial, Karl Kieburtz, Barbara C Tilley, et al.
Parkinsonism & Related Disorders|April 8, 2018
Relationship between the MDS-UPDRS and Quality of Life: A large multicenter study of 3206 patientsMatej Skorvanek, Pablo Martinez-Martin, Norbert Kovacs, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|July 24, 2008
Huntington CAG repeat size does not modify onset age in familial Parkinson's disease: the GenePD studyChristopher F McNicoll, Jeanne C Latourelle, Marcy E MacDonald, et al.
Human Genetics|July 1, 2008
Replication of association between ELAVL4 and Parkinson disease: the GenePD studyAnita L DeStefano, Jeanne Latourelle, Mark F Lew, et al.
Movement Disorders Clinical Practice|October 27, 2018
Differences in MDS-UPDRS Scores Based on Hoehn and Yahr Stage and Disease DurationMatej Skorvanek, Pablo Martinez-Martin, Norbert Kovacs, et al.
Neurology|August 18, 2017
National randomized controlled trial of virtual house calls for Parkinson diseaseChristopher A Beck, Denise B Beran, Kevin M Biglan, et al.
Telemedicine Journal and E-Health : the Official Journal of the American Telemedicine Association|February 18, 2016
National Randomized Controlled Trial of Virtual House Calls for People with Parkinson's Disease: Interest and BarriersE Ray Dorsey, Meredith A Achey, Christopher A Beck, et al.
BMC Medicine|November 7, 2008
The Gly2019Ser mutation in LRRK2 is not fully penetrant in familial Parkinson's disease: the GenePD studyJeanne C Latourelle, Mei Sun, Mark F Lew, et al.
Neurology|December 4, 2016
A randomized, double-blind, placebo-controlled trial of coenzyme Q10 in Huntington diseaseAndrew McGarry, Michael McDermott, Karl Kieburtz, et al.
Journal of Clinical Medicine|November 19, 2020
Safety and Tolerability of SRX246, a Vasopressin 1a Antagonist, in Irritable Huntington's Disease Patients-A Randomized Phase 2 Clinical TrialMichael J Brownstein, Neal G Simon, Jeffrey D Long, et al.
Pageof 14

Showing results (121-130 of 133) with videos related to

Sort By:
Pageof 14
JAMA|February 11, 2015
Effect of creatine monohydrate on clinical progression in patients with Parkinson disease: a randomized clinical trial, Karl Kieburtz, Barbara C Tilley, et al.
Parkinsonism & Related Disorders|April 8, 2018
Relationship between the MDS-UPDRS and Quality of Life: A large multicenter study of 3206 patientsMatej Skorvanek, Pablo Martinez-Martin, Norbert Kovacs, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|July 24, 2008
Huntington CAG repeat size does not modify onset age in familial Parkinson's disease: the GenePD studyChristopher F McNicoll, Jeanne C Latourelle, Marcy E MacDonald, et al.
Human Genetics|July 1, 2008
Replication of association between ELAVL4 and Parkinson disease: the GenePD studyAnita L DeStefano, Jeanne Latourelle, Mark F Lew, et al.
Movement Disorders Clinical Practice|October 27, 2018
Differences in MDS-UPDRS Scores Based on Hoehn and Yahr Stage and Disease DurationMatej Skorvanek, Pablo Martinez-Martin, Norbert Kovacs, et al.
Neurology|August 18, 2017
National randomized controlled trial of virtual house calls for Parkinson diseaseChristopher A Beck, Denise B Beran, Kevin M Biglan, et al.
Telemedicine Journal and E-Health : the Official Journal of the American Telemedicine Association|February 18, 2016
National Randomized Controlled Trial of Virtual House Calls for People with Parkinson's Disease: Interest and BarriersE Ray Dorsey, Meredith A Achey, Christopher A Beck, et al.
BMC Medicine|November 7, 2008
The Gly2019Ser mutation in LRRK2 is not fully penetrant in familial Parkinson's disease: the GenePD studyJeanne C Latourelle, Mei Sun, Mark F Lew, et al.
Neurology|December 4, 2016
A randomized, double-blind, placebo-controlled trial of coenzyme Q10 in Huntington diseaseAndrew McGarry, Michael McDermott, Karl Kieburtz, et al.
Journal of Clinical Medicine|November 19, 2020
Safety and Tolerability of SRX246, a Vasopressin 1a Antagonist, in Irritable Huntington's Disease Patients-A Randomized Phase 2 Clinical TrialMichael J Brownstein, Neal G Simon, Jeffrey D Long, et al.
Pageof 14